News-Medical.Net on MSN
New skin-permeable polymer delivers insulin without needles
Innovative zwitterionic polymer facilitates insulin absorption through the skin, offering a painless alternative to ...
The "Rabies Virus Market - A Global and Regional Analysis: Focus on Country and Regional Analysis - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.
Make sure your dog or cat receives its first rabies shot at the age recommended by your vet and boosters thereafter.
PharmaJet®, a company that strives to improve the performance and outcomes of injectables with its needle-free injection technology, will present at the American Society of Tropical Medicine and ...
BCG (Bacillus Calmette - Guerin) vaccine is made from a treated (attenuated) live strain of bacterium derived from Mycobacterium bovis, a bacterium which typically causes tuberculosis (TB) in cattle ...
Skin issues in pets often mean chronic care, so let's explore the gap between client expectations and the reality of veterinary dermatology.
Discover the 'slow ageing' approach and the top non-surgical aesthetic treatments for women over 50. Learn what doctors recommend for double chin, nasolabial folds and cheekbones.
NoviThera is developing a novel anti Monoclonal anti Body treatment. The invention was made by Allan Wehnert, CEO of NoviThera in conjunction with Nordicus. NoviThera’s mission is to research and ...
The New York University School of Medicine and collaborators found that capillary-associated macrophages in skin decline with age, weakening microvascular repair and reducing perfusion in mice, with ...
The global rabies virus market is set for growth, fueled by advancements in vaccine technologies and increasing preventive immunization adoption. Innovations like recombinant nanoparticle-based ...
NoviThera ApS ("NoviThera"), a majority owned subsidiary of Nordicus Partners Corporation (OTCQB: NORD) ("Nordicus" or the "Company"), a financial ...
Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results